VISTAAR is a Regulatory Intelligence Platform that offers Global Regulatory, Clinical, and Compliance Requirements to BioPharma, Devices, Consumer Health, Cosmetics, and Digital Health industries. Combining smart technology and subject experts, it delivers up-to-date requirements and trusted insights accurately and rapidly. The platform boasts deep data sets and provides functionalities like regulatory requirements database and reports, health authority documents repository, global clinical trials repository, and marketed product labels compliance. Founded in 2013 and based in the United States, VISTAAR aims to provide these services at the best price point in the industry. With a focus on regulatory information management, VISTAAR's unique approach to combining technology and expertise has the potential to significantly streamline compliance processes for companies operating in sensitive industries. The platform's ability to deliver accurate and current insights alongside comprehensive database and reporting capabilities can assist organizations in making informed strategic decisions. However, as of now, there's no public information available about the last investment made in VISTAAR or the involved investors. Given the increasing importance of regulatory compliance, VISTAAR is positioned to capture significant market share and drive industry-wide changes in how regulatory information is managed.
There is no investment information
No recent news or press coverage available for VISTAAR.